Pediatrix Medical reports Q3 adjusted EPS 44c, consensus 37c

Reports Q3 revenue $511M, consensus $498.87M. “Our third quarter operating results modestly exceeded our expectations, driven primarily by strength in same-unit revenue,” said James Swift, M.D., CEO of Pediatrix Medical (MD) Group. “During the quarter, we successfully completed our previously announced transition to a hybrid revenue cycle management structure, and we remain on track to complete our portfolio management plans by the end of 2024. We believe that a more focused portfolio, with enhanced support for our affiliated practices, will enable stronger financial performance and benefit all of our stakeholders.”